UTI

SEC source: 0001261654-21-000095 · wf-form4_163978122354938.xml · nonDerivative · entry 2

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,905

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/10/2020.

SEC source: 0001261654-21-000095 · wf-form4_163978122354938.xml · nonDerivative · entry 1

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 12/10/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

SEC source: 0001261654-21-000093 · wf-form4_163978107997072.xml · derivative · entry 4

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,704

Underlying: Common Stock, $0.0001 par value · 7,852 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 12/10/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 12/10/2021.

SEC source: 0001261654-21-000093 · wf-form4_163978107997072.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,380

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/10/2020.

SEC source: 0001261654-21-000093 · wf-form4_163978107997072.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 12/10/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

SEC source: 0001261654-21-000079 · wf-form4_163917408978584.xml · derivative · entry 2

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,808

Underlying: Common Stock, $0.0001 par value · 19,379 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000079 · wf-form4_163917408978584.xml · derivative · entry 1

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,875

Underlying: Common Stock, $0.0001 par value · 36,336 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000091 · wf-form4_163917479970002.xml · derivative · entry 2

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,037

Underlying: Common Stock, $0.0001 par value · 12,261 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000091 · wf-form4_163917479970002.xml · derivative · entry 1

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,917

Underlying: Common Stock, $0.0001 par value · 22,990 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000089 · wf-form4_163917468321375.xml · derivative · entry 2

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,729

Underlying: Common Stock, $0.0001 par value · 14,094 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000089 · wf-form4_163917468321375.xml · derivative · entry 1

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,208

Underlying: Common Stock, $0.0001 par value · 26,427 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000085 · wf-form4_163917444116271.xml · derivative · entry 2

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,753

Underlying: Common Stock, $0.0001 par value · 39,537 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000085 · wf-form4_163917444116271.xml · derivative · entry 1

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,346

Underlying: Common Stock, $0.0001 par value · 74,132 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000087 · wf-form4_163917457107049.xml · derivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,829

Underlying: Common Stock, $0.0001 par value · 79,870 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000087 · wf-form4_163917457107049.xml · derivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,526

Underlying: Common Stock, $0.0001 par value · 149,757 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000081 · wf-form4_163917420814405.xml · derivative · entry 2

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,093

Underlying: Common Stock, $0.0001 par value · 14,151 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000081 · wf-form4_163917420814405.xml · derivative · entry 1

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,315

Underlying: Common Stock, $0.0001 par value · 26,534 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000083 · wf-form4_163917433133648.xml · derivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,574

Underlying: Common Stock, $0.0001 par value · 21,992 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000083 · wf-form4_163917433133648.xml · derivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,558

Underlying: Common Stock, $0.0001 par value · 41,235 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000077 · wf-form4_163917396046979.xml · derivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,066

Underlying: Common Stock, $0.0001 par value · 19,732 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000077 · wf-form4_163917396046979.xml · derivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,779

Underlying: Common Stock, $0.0001 par value · 36,998 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000075 · wf-form4_163917377769712.xml · derivative · entry 2

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,009

Underlying: Common Stock, $0.0001 par value · 13,516 shares

Expires 2024-12-08

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 8, 2022.

SEC source: 0001261654-21-000075 · wf-form4_163917377769712.xml · derivative · entry 1

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,725

Underlying: Common Stock, $0.0001 par value · 25,343 shares

Expires 2024-12-08

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2024 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2024, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-21-000063 · wf-form4_163217883154607.xml · derivative · entry 3

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,776

Underlying: Common Stock, $0.0001 par value · 1,918 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 9/15/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 9/15/2021.

SEC source: 0001261654-21-000063 · wf-form4_163217883154607.xml · nonDerivative · entry 2

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,387

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 9/15/2020.

SEC source: 0001261654-21-000063 · wf-form4_163217883154607.xml · nonDerivative · entry 1

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,918

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 9/15/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000065 · wf-form4_163217899284430.xml · derivative · entry 3

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,493

Underlying: Common Stock, $0.0001 par value · 3,777 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 9/15/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 9/15/2021.

SEC source: 0001261654-21-000065 · wf-form4_163217899284430.xml · nonDerivative · entry 2

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,755

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 9/15/2020.

SEC source: 0001261654-21-000065 · wf-form4_163217899284430.xml · nonDerivative · entry 1

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 9/15/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000061 · wf-form4_163182736491111.xml · derivative · entry 3

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,942

Underlying: Common Stock, $0.0001 par value · 5,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units have vested in full.

F4 · derivative.expiration_date: The restricted stock units have vested in full.

SEC source: 0001261654-21-000061 · wf-form4_163182736491111.xml · nonDerivative · entry 2

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,686

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 9/12/2018.

SEC source: 0001261654-21-000061 · wf-form4_163182736491111.xml · nonDerivative · entry 1

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 9/12/2018.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000050 · wf-form4_162034072663161.xml · nonDerivative · entry 1

Sanchez Loretta Lydia · CIK 0001860681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,862

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on May 4, 2021.

SEC source: 0001261654-21-000037 · wf-form4_161524591616975.xml · derivative · entry 3

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,429

Underlying: Common Stock, $0.0001 par value · 3,325 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal installments beginning on 3/2/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal installments beginning on 3/2/2021.

SEC source: 0001261654-21-000037 · wf-form4_161524591616975.xml · nonDerivative · entry 2

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,169

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 3/2/2020.

SEC source: 0001261654-21-000037 · wf-form4_161524591616975.xml · nonDerivative · entry 1

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 3/2/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000035 · wf-form4_161437948569802.xml · nonDerivative · entry 1

Brochick George W. · CIK 0001807493 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,461

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000033 · wf-form4_161437839897736.xml · nonDerivative · entry 1

DEVINCENZI ROBERT THOMAS · CIK 0001226186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,996

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000029 · wf-form4_161437785839773.xml · nonDerivative · entry 1

SRERE LINDA J · CIK 0001193863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,230

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000027 · wf-form4_161437757369473.xml · nonDerivative · entry 1

Blaszkiewicz David · CIK 0001536971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,267

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000031 · wf-form4_161437811619001.xml · nonDerivative · entry 1

TRAMMELL KENNETH R · CIK 0001239782 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,749

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000025 · wf-form4_161437740620379.xml · nonDerivative · entry 1

LENNOX WILLIAM J JR · CIK 0001597376 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,634

F1 · shares: The shares were issued as non-employee director compensation under the Universal Technical Institute, Inc. 2021 Equity Incentive Plan and the award was approved by the Compensation Committee of UTI's Board of Directors on February 24, 2021.

SEC source: 0001261654-21-000012 · wf-form4_161057645060122.xml · derivative · entry 3

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,216

Underlying: Common Stock, $0.0001 par value · 10,221 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000012 · wf-form4_161057645060122.xml · nonDerivative · entry 2

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,669

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000012 · wf-form4_161057645060122.xml · nonDerivative · entry 1

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,221

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000010 · wf-form4_161057627981342.xml · derivative · entry 4

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,635

Underlying: Common Stock, $0.0001 par value · 3,848 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000010 · wf-form4_161057627981342.xml · nonDerivative · entry 2

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,206

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000010 · wf-form4_161057627981342.xml · nonDerivative · entry 1

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000008 · wf-form4_161057613551220.xml · derivative · entry 3

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,334

Underlying: Common Stock, $0.0001 par value · 3,848 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000008 · wf-form4_161057613551220.xml · nonDerivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,707

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.